Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer

Abstract Background The aim of this study was to evaluate and compare the performance of intensity modulated radiation therapy (IMRT) plans, planned for low-field strength magnetic resonance (MR) guided linear accelerator (linac) delivery (labelled IMRT MRL plans), and clinical conventional volumetr...

Full description

Bibliographic Details
Main Authors: Vanessa Da Silva Mendes, Lukas Nierer, Minglun Li, Stefanie Corradini, Michael Reiner, Florian Kamp, Maximilian Niyazi, Christopher Kurz, Guillaume Landry, Claus Belka
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Radiation Oncology
Subjects:
Online Access:https://doi.org/10.1186/s13014-021-01858-7
id doaj-832cf5baf23b401e8f212610f5a5636b
record_format Article
spelling doaj-832cf5baf23b401e8f212610f5a5636b2021-07-25T11:15:34ZengBMCRadiation Oncology1748-717X2021-07-0116111210.1186/s13014-021-01858-7Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancerVanessa Da Silva Mendes0Lukas Nierer1Minglun Li2Stefanie Corradini3Michael Reiner4Florian Kamp5Maximilian Niyazi6Christopher Kurz7Guillaume Landry8Claus Belka9Department of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichAbstract Background The aim of this study was to evaluate and compare the performance of intensity modulated radiation therapy (IMRT) plans, planned for low-field strength magnetic resonance (MR) guided linear accelerator (linac) delivery (labelled IMRT MRL plans), and clinical conventional volumetric modulated arc therapy (VMAT) plans, for the treatment of prostate cancer (PCa). Both plans used the original planning target volume (PTV) margins. Additionally, the potential dosimetric benefits of MR-guidance were estimated, by creating IMRT MRL plans using smaller PTV margins. Materials and methods 20 PCa patients previously treated with conventional VMAT were considered. For each patient, two different IMRT MRL plans using the low-field MR-linac treatment planning system were created: one with original (orig.) PTV margins and the other with reduced (red.) PTV margins. Dose indices related to target coverage, as well as dose-volume histogram (DVH) parameters for the target and organs at risk (OAR) were compared. Additionally, the estimated treatment delivery times and the number of monitor units (MU) of each plan were evaluated. Results The dose distribution in the high dose region and the target volume DVH parameters (D98%, D50%, D2% and V95%) were similar for all three types of treatment plans, with deviations below 1% in most cases. Both IMRT MRL plans (orig. and red. PTV margins) showed similar homogeneity indices (HI), however worse values for the conformity index (CI) were also found when compared to VMAT. The IMRT MRL plans showed similar OAR sparing when the orig. PTV margins were used but a significantly better sparing was feasible when red. PTV margins were applied. Higher number of MU and longer predicted treatment delivery times were seen for both IMRT MRL plans. Conclusions A comparable plan quality between VMAT and IMRT MRL plans was achieved, when applying the same PTV margin. However, online MR-guided adaptive radiotherapy allows for a reduction of PTV margins. With a red. PTV margin, better sparing of the surrounding tissues can be achieved, while maintaining adequate target coverage. Nonetheless, longer treatment delivery times, characteristic for the IMRT technique, have to be expected.https://doi.org/10.1186/s13014-021-01858-7IMRTVMATIGRTMR-guidanceMRIdian linacLow-field MR-linac
collection DOAJ
language English
format Article
sources DOAJ
author Vanessa Da Silva Mendes
Lukas Nierer
Minglun Li
Stefanie Corradini
Michael Reiner
Florian Kamp
Maximilian Niyazi
Christopher Kurz
Guillaume Landry
Claus Belka
spellingShingle Vanessa Da Silva Mendes
Lukas Nierer
Minglun Li
Stefanie Corradini
Michael Reiner
Florian Kamp
Maximilian Niyazi
Christopher Kurz
Guillaume Landry
Claus Belka
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
Radiation Oncology
IMRT
VMAT
IGRT
MR-guidance
MRIdian linac
Low-field MR-linac
author_facet Vanessa Da Silva Mendes
Lukas Nierer
Minglun Li
Stefanie Corradini
Michael Reiner
Florian Kamp
Maximilian Niyazi
Christopher Kurz
Guillaume Landry
Claus Belka
author_sort Vanessa Da Silva Mendes
title Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
title_short Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
title_full Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
title_fullStr Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
title_full_unstemmed Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
title_sort dosimetric comparison of mr-linac-based imrt and conventional vmat treatment plans for prostate cancer
publisher BMC
series Radiation Oncology
issn 1748-717X
publishDate 2021-07-01
description Abstract Background The aim of this study was to evaluate and compare the performance of intensity modulated radiation therapy (IMRT) plans, planned for low-field strength magnetic resonance (MR) guided linear accelerator (linac) delivery (labelled IMRT MRL plans), and clinical conventional volumetric modulated arc therapy (VMAT) plans, for the treatment of prostate cancer (PCa). Both plans used the original planning target volume (PTV) margins. Additionally, the potential dosimetric benefits of MR-guidance were estimated, by creating IMRT MRL plans using smaller PTV margins. Materials and methods 20 PCa patients previously treated with conventional VMAT were considered. For each patient, two different IMRT MRL plans using the low-field MR-linac treatment planning system were created: one with original (orig.) PTV margins and the other with reduced (red.) PTV margins. Dose indices related to target coverage, as well as dose-volume histogram (DVH) parameters for the target and organs at risk (OAR) were compared. Additionally, the estimated treatment delivery times and the number of monitor units (MU) of each plan were evaluated. Results The dose distribution in the high dose region and the target volume DVH parameters (D98%, D50%, D2% and V95%) were similar for all three types of treatment plans, with deviations below 1% in most cases. Both IMRT MRL plans (orig. and red. PTV margins) showed similar homogeneity indices (HI), however worse values for the conformity index (CI) were also found when compared to VMAT. The IMRT MRL plans showed similar OAR sparing when the orig. PTV margins were used but a significantly better sparing was feasible when red. PTV margins were applied. Higher number of MU and longer predicted treatment delivery times were seen for both IMRT MRL plans. Conclusions A comparable plan quality between VMAT and IMRT MRL plans was achieved, when applying the same PTV margin. However, online MR-guided adaptive radiotherapy allows for a reduction of PTV margins. With a red. PTV margin, better sparing of the surrounding tissues can be achieved, while maintaining adequate target coverage. Nonetheless, longer treatment delivery times, characteristic for the IMRT technique, have to be expected.
topic IMRT
VMAT
IGRT
MR-guidance
MRIdian linac
Low-field MR-linac
url https://doi.org/10.1186/s13014-021-01858-7
work_keys_str_mv AT vanessadasilvamendes dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT lukasnierer dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT minglunli dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT stefaniecorradini dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT michaelreiner dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT floriankamp dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT maximilianniyazi dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT christopherkurz dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT guillaumelandry dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
AT clausbelka dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer
_version_ 1721283313411293184